Wow! Taiwan Project

About Company

Glonova Pharma Co., Ltd. Founded in 2018, aimed to mark breakthroughs, newer, more effective and safter products. The initial three products will provide solutions for localized fat reduction in the human body. In addition to the benefits of safety, quality, and convenience, these products are also patented innovative medications. The first product, "Ronkyla Injection" has already received approval from the Taiwan Ministry of Health and Welfare and is successfully on the market. In the subsequent phase of new product development, the focus will be on further improving the existing products, leading to "Ronkyla Gel" and "Ronkyla Plus" These products aim to achieve better therapeutic effects with fewer side effects, offering healthcare professionals better choices. This allows patients to undergo treatment without undue burden, build self-confidence, and pursue a better quality of life.

Product Name

Ronkyla Injection Range

Product Info

1. Taiwan FDA approved in October, 2021

2. Ronkyla® (sodium deoxycholate) is a cytolysis agent indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults (also called “double chin”.

3. Prescription medicine Ronkyla® should be administered by healthcare professional.